🔬A new clue to why cancer immunotherapy works for some patients, but not others
A new Technion-led study suggests that the key may lie in what happens during the first weeks of treatment.
Led by Prof. @dvir_a , together with first author Dr. Zhongyang Lin and international
Technion ~ Israel Institute of Technology. Over 100 years of commitment to science, technology, innovation & education.

